Prices delayed by at least 15 minutes | Print
Tenax Therapeutics (TENX)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.
Address
ONE Copley Parkway
Suite 490
Morrisville
NC
USA
27560
Telephone
+1 212 3621200
Forecast key dates
| Name | Key Date |
|---|---|
| Tenax Therapeutics Inc Annual Report for 2024 | 2025-03-28T00:00:00 |
| Tenax Therapeutics Inc Third Quarter Earnings Results for 2024 | 2024-11-13T00:00:00 |
| Tenax Therapeutics Inc Second Quarter Earnings Results for 2024 | 2024-08-14T00:00:00 |
| Tenax Therapeutics Inc Annual General Meeting for 2024 | 2024-05-31T09:00:00 |
| Tenax Therapeutics Inc First Quarter Earnings Results for 2024 | 2024-05-15T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Tenax Therapeutics Inc Annual General Meeting for 2024 | 2024-05-31T09:00:00 |
| Tenax Therapeutics Inc First Quarter Earnings Results for 2024 | 2024-05-15T00:00:00 |
| Tenax Therapeutics Inc Annual General Meeting for 2023 | 2024-04-29T00:00:00 |
| Tenax Therapeutics Inc Annual Report for 2023 | 2024-03-28T00:00:00 |
| Tenax Therapeutics to Present at the 36th Annual Roth Conference | 2024-03-18T15:00:00 |
| Tenax Therapeutics Inc Third Quarter Earnings Results for 2023 | 2023-11-13T00:00:00 |
| Tenax Therapeutics Inc Second Quarter Earnings Results for 2023 | 2023-08-14T00:00:00 |
| Tenax Therapeutics Inc First Quarter Earnings Results for 2023 | 2023-05-15T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.